These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27260699)

  • 1. Epilepsy in multiple sclerosis: The role of temporal lobe damage.
    Calabrese M; Castellaro M; Bertoldo A; De Luca A; Pizzini FB; Ricciardi GK; Pitteri M; Zimatore S; Magliozzi R; Benedetti MD; Manganotti P; Montemezzi S; Reynolds R; Gajofatto A; Monaco S
    Mult Scler; 2017 Mar; 23(3):473-482. PubMed ID: 27260699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal cortical thinning in patients with stable relapsing-remitting multiple sclerosis: cross-sectional-based novel estimation of gray matter kinetics.
    Orbach L; Menascu S; Hoffmann C; Miron S; Achiron A
    Neuroradiology; 2018 Feb; 60(2):179-187. PubMed ID: 29285552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis.
    Crescenzo F; Marastoni D; Zuco C; Pitteri M; Magliozzi R; Monaco S; Calabrese M
    Mult Scler Relat Disord; 2019 Jan; 27():305-311. PubMed ID: 30453199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients.
    Hojjat SP; Cantrell CG; Vitorino R; Feinstein A; Shirzadi Z; MacIntosh BJ; Crane DE; Zhang L; Morrow SA; Lee L; O'Connor P; Carroll TJ; Aviv RI
    Mult Scler; 2016 Oct; 22(11):1421-1428. PubMed ID: 26754799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.
    Gracien RM; Jurcoane A; Wagner M; Reitz SC; Mayer C; Volz S; Hof SM; Fleischer V; Droby A; Steinmetz H; Groppa S; Hattingen E; Deichmann R; Klein JC
    J Magn Reson Imaging; 2016 Dec; 44(6):1600-1607. PubMed ID: 27153293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
    Calabrese M; Reynolds R; Magliozzi R; Castellaro M; Morra A; Scalfari A; Farina G; Romualdi C; Gajofatto A; Pitteri M; Benedetti MD; Monaco S
    PLoS One; 2015; 10(8):e0135428. PubMed ID: 26267665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study.
    Calabrese M; Grossi P; Favaretto A; Romualdi C; Atzori M; Rinaldi F; Perini P; Saladini M; Gallo P
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):49-54. PubMed ID: 21890577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low degree of cortical pathology is associated with benign course of multiple sclerosis.
    Calabrese M; Favaretto A; Poretto V; Romualdi C; Rinaldi F; Mattisi I; Morra A; Perini P; Gallo P
    Mult Scler; 2013 Jun; 19(7):904-11. PubMed ID: 23069877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Gray and White Matter Abnormalities to Cognitive Impairment in Multiple Sclerosis.
    Zhang X; Zhang F; Huang D; Wu L; Ma L; Liu H; Zhao Y; Yu S; Shi J
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
    Sethi V; Yousry T; Muhlert N; Tozer DJ; Altmann D; Ron M; Wheeler-Kingshott C; Miller DH; Chard DT
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):750-3. PubMed ID: 26272028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.
    Meijboom R; York EN; Kampaite A; Harris MA; White N; Valdés Hernández MDC; Thrippleton MJ; MacDougall NJJ; Connick P; Hunt DPJ; Chandran S; Waldman AD;
    PLoS One; 2023; 18(7):e0288967. PubMed ID: 37506096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
    Dong X; Xu G; Wang J; Yin N; Meng N
    Mult Scler Relat Disord; 2022 Sep; 65():103838. PubMed ID: 35749960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis.
    Meijer KA; Eijlers AJC; Geurts JJG; Schoonheim MM
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):205-210. PubMed ID: 28986469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of cortical grey matter thickness reduction in multiple sclerosis.
    Fujimori J; Fujihara K; Wattjes M; Nakashima I
    Brain Behav; 2021 Apr; 11(4):e02050. PubMed ID: 33506628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
    Calabrese M; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Romualdi C; Rinaldi L; Perini P; Gallo P
    Neurology; 2010 Jan; 74(4):321-8. PubMed ID: 20101038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.